Starpharma Holdings Limited (ASX:SPL)
Australia flag Australia · Delayed Price · Currency is AUD
0.7500
0.00 (0.00%)
Jul 31, 2026, 4:10 PM AEST

Starpharma Holdings Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
3163739127302607
Market Cap Growth
694.99%-5.98%-69.24%-57.90%-50.21%44.84%
Enterprise Value
298191091255538
Last Close Price
0.750.090.090.300.721.46

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Forward PE
-34.9434.9434.9434.9434.94
PS Ratio
21.676.294.0129.3058.55174.10
PB Ratio
14.711.941.393.666.259.74
P/TBV Ratio
14.711.941.393.666.259.74

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
EV/Sales Ratio
20.473.251.0420.9749.34154.38

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Debt / Equity Ratio
0.040.130.130.240.170.02
Net Debt / Equity Ratio
-0.81-0.68-0.70-0.77-0.86-0.95
Net Debt / EBITDA Ratio
5.891.342.531.772.643.05
Net Debt / FCF Ratio
15.871.912.811.802.983.94
Asset Turnover
0.520.190.220.070.070.06
Inventory Turnover
4.954.434.134.426.3614.33
Quick Ratio
4.863.764.463.005.656.61
Current Ratio
5.264.324.943.265.936.78
Return on Equity (ROE)
-14.47%-42.41%-25.95%-37.59%-29.19%-42.15%
Return on Assets (ROA)
-7.24%-20.06%-11.48%-16.53%-14.48%-21.96%
Return on Capital Employed (ROCE)
-15.00%-49.50%-27.10%-41.60%-28.90%-31.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Earnings Yield
-1.02%-27.14%-20.86%-12.29%-5.34%-3.25%
FCF Yield
-0.35%-18.48%-18.05%-11.73%-4.63%-2.48%
Buyback Yield / Dilution
-1.07%-1.40%-0.59%-0.53%-2.53%-6.62%